News

A study published in The New England Journal of Medicine has identified two genetic variants associated with COVID-19 respiratory failure.

Research labs are racing to develop innovative testing methods and overcome the bottlenecks to more widespread testing, which is crucial to controlling the spread of the disease.

Researchers have developed a new test to better diagnose different types of ovarian cancer, a tool that could improve treatment options for those diagnosed with the most common and deadliest form of the disease.

Scientists at the University of Sussex have identified a potential pattern within blood which signals the presence of amyotrophic lateral sclerosis; a discovery which could significantly improve diagnosis.

A new method of analysing cancer patients’ blood for evidence of the disease could be up to ten times more sensitive than previous methods according to new research led by the University of Cambridge.

In a new proof-of-concept study in ACS Sensors, researchers describe a new system for detecting antibodies within a pinprick of blood within minutes, using an unlikely combination of cotton thread, glowing proteins and a smartphone camera.

In this study, scientists show that even brief exposure to certain chemicals while the liver is developing prematurely aged the liver epigenome.

New research examined the urinary metabolome of healthy newborns to aid in improving the diagnosis of disease in infants.

The American Red Cross has begun testing all blood, platelet and plasma donations for COVID-19 antibodies. During these uncertain times, the Red Cross hopes that testing for COVID-19 antibodies will provide its valued donors insight into whether they may have been exposed to this coronavirus.

Dexamethasone reduces death in hospitalized patients with severe respiratory complications of COVID-19.